Skin Cancer

Highest risk of multiple primary melanomas from indoor tanning

Findings from a case-control study show that a history of indoor tanning is the strongest risk factor for the development of multiple...

Nivolumab shows promise in advanced cutaneous squamous cell carcinoma

Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...

Models predict low mortality in certain patients with stage 1 melanoma

According to a new study, models based on cancer registry data can help identify subsets of stage 1 melanoma patients with very low...

Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery

Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...

New molecule may block melanoma growth

Researchers at Emory University in Atlanta have synthesized a novel molecule called indolium 1 that blocks the growth of melanoma cells,...

New technology for rapid bedside skin cancer biopsy diagnosis

A pilot study of a new biopsy imaging system has shown high accuracy in diagnosing non-melanoma skin cancer in two minutes—substantially...

VIDEO: Suppressing key metabolic enzyme may stop melanoma growth, new study shows

A new study has discovered that by inhibiting the key metabolic enzyme GCDH, melanoma cells can be selectively killed to halt tumour growth.

Lack of melanin precursor DOPA may lead to melanoma in people with lighter skin

People with lighter skin tones may be more susceptible to melanoma not only due to a lack of UV-protective melanin, but because of a lack...

1

it's where dermatology lives